Literature DB >> 17030523

Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study.

Sing-Chien Yap1, Jolien W Roos-Hesselink, Elke S Hoendermis, Werner Budts, Hubert W Vliegen, Barbara J M Mulder, Arie P J van Dijk, Martin J Schalij, Willem Drenthen.   

Abstract

AIMS: To investigate outcome and complications of implantable cardioverter defibrillators (ICDs) in adults with congenital heart disease (CHD) and to identify predictors of (in-) appropriate shocks. METHODS AND
RESULTS: Sixty-four CHD patients >/= 18 years at first ICD implantation [63% tetralogy of Fallot (TOF) and age at implantation 37 +/- 13 years] were identified using the Dutch adult CHD registry and a Belgian tertiary care centre database. Median follow-up duration was 3.7 years. Early complications included pocket haematoma (n = 3), lead failure (n = 2), and pneumothorax (n = 2). Late complications occurred in 11 (17%) patients, including lead failure (n = 6) and and electrical storm (n = 3). Overall, 30 device-related re-interventions were performed in 20 patients (31%), including four premature generator changes and seven lead replacements. Half of the patients received one or more shocks, and 46 shocks in 15 patients (23%) were classified as appropriate. One hundred and sixty shocks in 26 patients (41%) were classified as inappropriate. No predictors of (in-)appropriate shocks were identified, except TOF being associated with less appropriate shocks than patients with other CHD (HR 0.29, P = 0.02).
CONCLUSION: The ICD provided effective therapy in a quarter of adults with CHD with low complication rates. The incidence of inappropriate shocks, however, appeared to be excessive and warrants further attention.

Entities:  

Mesh:

Year:  2006        PMID: 17030523     DOI: 10.1093/eurheartj/ehl306

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  19 in total

1.  Cardioverter-defibrillators for primary and secondary prevention in adults with tetralogy of fallot.

Authors:  Elyse Foster
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

Review 2.  Arrhythmias in structural heart disease.

Authors:  H Sawyer Gillespie; Charles C H Lin; Jordan M Prutkin
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

3.  Pacing and Defibrillators in Complex Congenital Heart Disease.

Authors:  Henry Chubb; Mark O'Neill; Eric Rosenthal
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

4.  Clinical research priorities in adult congenital heart disease.

Authors:  Timothy Cotts; Paul Khairy; Alexander R Opotowsky; Anitha S John; Anne Marie Valente; Ali N Zaidi; Stephen C Cook; Jamil Aboulhosn; Jennifer Grando Ting; Michelle Gurvitz; Michael J Landzberg; Amy Verstappen; Joseph Kay; Michael Earing; Wayne Franklin; Brian Kogon; Craig S Broberg
Journal:  Int J Cardiol       Date:  2013-12-24       Impact factor: 4.164

Review 5.  Narrative review of: risk stratification and implantable cardioverter-defibrillator therapy in adults with congenital heart disease.

Authors:  Julia Köbe; Kevin Willy; Lars Eckardt; Helmut Baumgartner; Kristina Wasmer
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

6.  Managing heart failure in adults with congenital heart disease.

Authors:  Thomas D Ryan; John L Jefferies; Ivan Wilmot
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-02

7.  Multicenter study of the effectiveness of implantable cardioverter defibrillators in children and young adults with heart disease.

Authors:  Nicholas H Von Bergen; Dianne L Atkins; Macdonald Dick; David J Bradley; Susan P Etheridge; Elizabeth V Saarel; Peter S Fischbach; Seshadri Balaji; Narayanswami Sreeram; William N Evans; Ian H Law
Journal:  Pediatr Cardiol       Date:  2011-01-06       Impact factor: 1.655

8.  Device therapy to prevent sudden death in patients with structural heart disease.

Authors:  N Sreeram; U Trieschmann; M Emmel; M Khalil
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05

Review 9.  Primary Prevention of Sudden Cardiac Death in Adults with Transposition of the Great Arteries: A Review of Implantable Cardioverter-Defibrillator Placement.

Authors:  Sandeep S Sodhi; Ari M Cedars
Journal:  Tex Heart Inst J       Date:  2015-08-01

10.  The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator Shocks in Patients With Tetralogy of Fallot.

Authors:  Satoshi Kawada; Praloy Chakraborty; Eugene Downar; Andreu-Porta Sanchez; Gnalini Sathananthan; Abhishek Bhaskaran; Priyanka Kugamoorthy; Lisa Albertini; Erwin N Oechslin; Candice Silversides; Rachel M Wald; Susan Lucy Roche; Lorna Swan; Rafael Alonso-Gonzalez; Sara Thorne; Louise Harris; Edward Hickey; Kumaraswamy Nanthakumar; Blandine Mondésert; Paul Khairy; Krishnakumar Nair
Journal:  CJC Open       Date:  2021-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.